DE3853422D1 - HIV-3-Retrovirus und seine Verwendung. - Google Patents
HIV-3-Retrovirus und seine Verwendung.Info
- Publication number
- DE3853422D1 DE3853422D1 DE3853422T DE3853422T DE3853422D1 DE 3853422 D1 DE3853422 D1 DE 3853422D1 DE 3853422 T DE3853422 T DE 3853422T DE 3853422 T DE3853422 T DE 3853422T DE 3853422 D1 DE3853422 D1 DE 3853422D1
- Authority
- DE
- Germany
- Prior art keywords
- hiv
- retrovirus
- nucleic acid
- acid sequence
- region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010020164 HIV infection CDC Group III Diseases 0.000 title abstract 6
- 241001430294 unidentified retrovirus Species 0.000 title abstract 4
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 101800001690 Transmembrane protein gp41 Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical group 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 101710121417 Envelope glycoprotein Proteins 0.000 abstract 1
- 102100021696 Syncytin-1 Human genes 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/974—Aids related test
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
- Y10S530/809—Fused cells, e.g. hybridoma
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP88109200A EP0345375B1 (de) | 1988-06-09 | 1988-06-09 | HIV-3-Retrovirus und seine Verwendung |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3853422D1 true DE3853422D1 (de) | 1995-04-27 |
DE3853422T2 DE3853422T2 (de) | 1995-10-26 |
Family
ID=8199044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3853422T Expired - Lifetime DE3853422T2 (de) | 1988-06-09 | 1988-06-09 | HIV-3-Retrovirus und seine Verwendung. |
Country Status (10)
Country | Link |
---|---|
US (7) | US5304466A (de) |
EP (3) | EP0345375B1 (de) |
JP (1) | JP2882654B2 (de) |
AT (1) | ATE120234T1 (de) |
AU (1) | AU625970B2 (de) |
CY (1) | CY2051B1 (de) |
DE (1) | DE3853422T2 (de) |
DK (1) | DK176078B1 (de) |
ES (1) | ES2072853T3 (de) |
WO (1) | WO1989012094A1 (de) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5364933A (en) | 1986-03-03 | 1994-11-15 | Institut Pasteur | Methods of immunopurification of antigens of human immunodeficiency virus type 2 (HIV-2) |
DE3853422T2 (de) * | 1988-06-09 | 1995-10-26 | Innogenetics Nv | HIV-3-Retrovirus und seine Verwendung. |
DK0494317T4 (da) * | 1990-06-15 | 2001-04-02 | Innogenetics Nv | SIV cpz-ant-retrovirus og anvendelse deraf |
US6667387B1 (en) | 1996-09-30 | 2003-12-23 | N.V. Innogenetics S.A. | HCV core peptides |
US6709828B1 (en) | 1992-03-06 | 2004-03-23 | N.V. Innogenetics S.A. | Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
EP0589004B2 (de) * | 1992-03-06 | 2004-05-06 | N.V. Innogenetics S.A. | Verfahren zur bestimmung von peptiden, die immunologisch wichtigen epitopen von hcv zugehörig sind |
EP0591914B2 (de) | 1992-10-06 | 2010-02-10 | Siemens Healthcare Diagnostics Products GmbH | Retrovirus aus der HIV-Gruppe und dessen Verwendung |
DE4405810A1 (de) * | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
GB9410044D0 (en) * | 1994-05-19 | 1994-07-06 | Int Murex Tech Corp | Assay |
CA2652992C (fr) | 1994-10-20 | 2014-10-07 | Institut Pasteur | Sequences nucleotidiques d'antigenes retroviraux vih-1 groupe (ou sous-groupe) o |
US5599662A (en) * | 1995-02-17 | 1997-02-04 | Hoffmann-La Roche Inc. | Oliconucleotide primers and probes for the detection of HIV-1 |
DE69632535T2 (de) * | 1995-06-07 | 2005-06-02 | Abbott Laboratories, Abbott Park | Peptide zur detektion von hiv-1 |
US5612473A (en) * | 1996-01-16 | 1997-03-18 | Gull Laboratories | Methods, kits and solutions for preparing sample material for nucleic acid amplification |
ATE228248T1 (de) † | 1997-03-10 | 2002-12-15 | Roche Diagnostics Gmbh | Verfahren zur simultanen bestimmung von hiv- antigenen und hiv-antikörpern |
US5922533A (en) * | 1997-08-15 | 1999-07-13 | Abbott Laboratories | Rapid assay for simultaneous detection and differentiation of antibodies to HIV groups |
US6846905B2 (en) | 1997-08-15 | 2005-01-25 | Abbott Laboratories | Antigen constructs useful in the detection and differentiation of antibodies to HIV |
US7244570B2 (en) | 1998-08-04 | 2007-07-17 | Luminex Molecular Diagnostics, Inc. | Methods and compositions for modulating “marginally indiscriminant” hybridizations |
US6235479B1 (en) | 1999-04-13 | 2001-05-22 | Bio Merieux, Inc. | Methods and devices for performing analysis of a nucleic acid sample |
ATE456677T1 (de) * | 1999-07-09 | 2010-02-15 | Gen Probe Inc | Hiv-1 detektion mittels nukleinsäureamplifizierung |
AP1674A (en) | 1999-11-16 | 2006-10-30 | Geneart Ag | The genome of the HIV-1 inter-subtype (C/B') and use thereof. |
US6582920B2 (en) | 2000-09-01 | 2003-06-24 | Gen-Probe Incorporated | Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations |
US6818392B2 (en) | 2000-12-06 | 2004-11-16 | Abbott Laboratories | Monoclonal antibodies to human immunodeficiency virus and uses thereof |
US20030175950A1 (en) * | 2001-05-29 | 2003-09-18 | Mcswiggen James A. | RNA interference mediated inhibition of HIV gene expression using short interfering RNA |
WO2003098215A1 (en) * | 2002-05-16 | 2003-11-27 | Medmira Inc. | Rapid vaccinia antibody detection device, method and test kit |
US7611712B2 (en) * | 2003-10-23 | 2009-11-03 | Nelson M. Karp | Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide |
EP2211873B1 (de) * | 2007-10-22 | 2012-08-08 | Amorphical Ltd. | Stabiles amorphes Calciumcarbonat mit phosphorylierten Aminosäuren |
WO2011119920A2 (en) | 2010-03-25 | 2011-09-29 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
HUE037408T2 (hu) | 2011-06-10 | 2018-08-28 | Univ Oregon Health & Science | CMV glikoproteinek és rekombináns vektorok |
CA2789539A1 (en) | 2011-09-12 | 2013-03-12 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
EP2586461A1 (de) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Von einem eingehüllten Virus abgeleitete Virenpartikel |
ES2631608T3 (es) | 2012-06-27 | 2017-09-01 | International Aids Vaccine Initiative | Variante de la glicoproteína Env del VIH-1 |
US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
EP2873423B1 (de) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
US10174292B2 (en) | 2015-03-20 | 2019-01-08 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
EP3072901A1 (de) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
WO2016193983A1 (en) | 2015-06-04 | 2016-12-08 | Amorphical Ltd. | Compositions of amorphous calcium carbonate for inhalation, sublingual or buccal administration |
CN114948992A (zh) | 2016-10-25 | 2022-08-30 | 艾玛菲克有限公司 | 用于治疗白血病的无定形碳酸钙 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5217861A (en) * | 1983-09-15 | 1993-06-08 | Institut Pasteur | Antigen of a human retrovirus, namely p18 protein of human immunodeficiency virus (HIV), compositions containing the antigen, a diagnostic method for detecting acquired immune deficiency syndrome (AIDS) and pre-AIDS and a kit therefor |
DE3588248T2 (de) * | 1984-10-18 | 2004-07-01 | Institut Pasteur | LAV-Antigene und -Peptide |
DE3752319T2 (de) * | 1986-01-22 | 2001-03-15 | Pasteur Institut | Prozess zur rekombinanten Herstellung von HIV-2 - Proteinen sowie Zellen, die HIV-2 - Proteine exprimiert |
US4839288A (en) * | 1986-01-22 | 1989-06-13 | Institut Pasteur | Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes |
US5066782A (en) * | 1986-01-22 | 1991-11-19 | Institut Pasteur | Retrovirus capable of causing AIDS, means and method for detecting it in vitro |
US5030714A (en) * | 1986-06-23 | 1991-07-09 | Institut Pasteur | Variant of LAV viruses |
US5166050A (en) * | 1986-08-20 | 1992-11-24 | Bristol-Myers Squibb Company | Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections |
SE8701765L (sv) * | 1987-04-28 | 1988-10-29 | Statens Bakteriologiska Lab | Analysmetod och medel foer denna |
DE3853422T2 (de) * | 1988-06-09 | 1995-10-26 | Innogenetics Nv | HIV-3-Retrovirus und seine Verwendung. |
-
1988
- 1988-06-09 DE DE3853422T patent/DE3853422T2/de not_active Expired - Lifetime
- 1988-06-09 EP EP88109200A patent/EP0345375B1/de not_active Expired - Lifetime
- 1988-06-09 ES ES88109200T patent/ES2072853T3/es not_active Expired - Lifetime
- 1988-06-09 AT AT88109200T patent/ATE120234T1/de not_active IP Right Cessation
- 1988-06-09 EP EP03008364A patent/EP1369427A3/de not_active Withdrawn
- 1988-06-09 EP EP94110658A patent/EP0657532B1/de not_active Revoked
-
1989
- 1989-06-08 AU AU37628/89A patent/AU625970B2/en not_active Expired
- 1989-06-08 JP JP1506144A patent/JP2882654B2/ja not_active Expired - Lifetime
- 1989-06-08 US US07/460,913 patent/US5304466A/en not_active Expired - Lifetime
- 1989-06-08 WO PCT/EP1989/000643 patent/WO1989012094A1/en unknown
-
1990
- 1990-02-08 DK DK199000331A patent/DK176078B1/da not_active IP Right Cessation
-
1994
- 1994-04-15 US US08/228,519 patent/US5567603A/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/486,836 patent/US5795743A/en not_active Expired - Lifetime
- 1995-06-07 US US08/474,360 patent/US5858647A/en not_active Expired - Lifetime
-
1997
- 1997-07-25 US US08/900,902 patent/US6013484A/en not_active Expired - Lifetime
-
1998
- 1998-04-30 CY CY9802051A patent/CY2051B1/xx unknown
-
1999
- 1999-08-23 US US09/379,270 patent/US6265200B1/en not_active Expired - Fee Related
-
2001
- 2001-05-09 US US09/851,664 patent/US20030039954A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030039954A1 (en) | 2003-02-27 |
ES2072853T3 (es) | 1995-08-01 |
ATE120234T1 (de) | 1995-04-15 |
JPH02504583A (ja) | 1990-12-27 |
US5567603A (en) | 1996-10-22 |
EP1369427A2 (de) | 2003-12-10 |
AU625970B2 (en) | 1992-07-23 |
US5795743A (en) | 1998-08-18 |
EP0345375A1 (de) | 1989-12-13 |
WO1989012094A1 (en) | 1989-12-14 |
EP0657532A1 (de) | 1995-06-14 |
CY2051B1 (en) | 1998-04-30 |
EP0345375B1 (de) | 1995-03-22 |
EP1369427A3 (de) | 2004-05-12 |
AU3762889A (en) | 1990-01-05 |
DK33190D0 (da) | 1990-02-08 |
DE3853422T2 (de) | 1995-10-26 |
US6013484A (en) | 2000-01-11 |
US5304466A (en) | 1994-04-19 |
DK176078B1 (da) | 2006-04-10 |
JP2882654B2 (ja) | 1999-04-12 |
EP0657532B1 (de) | 2003-12-17 |
DK33190A (da) | 1990-03-28 |
US6265200B1 (en) | 2001-07-24 |
US5858647A (en) | 1999-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3853422D1 (de) | HIV-3-Retrovirus und seine Verwendung. | |
Cafaro et al. | Control of SHIV-89.6 P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine | |
Salminen et al. | Full-length sequence of an Ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C | |
CA2009403C (en) | A packaging defective hiv provirus, cell lines, and uses thereof | |
NO921969L (no) | Ikke-replikerende rekombinant fremstilte retroviruspartikler brukt som antivirale midler og immunogener | |
DE69535757D1 (de) | Rekombinanter immunschwächepoxvirus | |
NO874750L (no) | Bestemte dna-sekvenser avledet fra et papillomavirusgenom, deres bruk i in vitro diagnostikk og produksjon av antigene preparater. | |
ES2099066T3 (es) | Antigenos a partir de adn sintetico derivado del virus de la inmunodeficiencia humana (hiv-1). | |
CA2107732A1 (en) | Retrovirus from the hiv group and its use | |
EP0512017A1 (de) | Vakzine. | |
ATE362379T1 (de) | Induktion rev- und tat-spezifischer zytotoxischer t-zellen zur prävention und behandlung einer infektion durch humanen immundefizienz-virus (hiv) | |
DK513388A (da) | Peptider med immunologiske egenskaber svarende til hiv-2 virus, nucleotidsekvenser, der koder for saadanne peptider, antigene og immunogene midler indeholdende saadanne peptider samt fremgangsmaade og kit til in vitro diagnose af hiv-2 | |
KR950032278A (ko) | 사람 면역결핍 바이러스 그룹의 레트로바이러스로부터 유래된 펩타이드 및 이의 용도 | |
DE60026199T2 (de) | Synthetische Gene für gagpol und deren Verwendungen | |
EP0342860A3 (de) | Neues Protein, Sequenze mit enthaltendem Gene, Vektoren, Verfahren zur Herstellung und Verwendung | |
ATE135743T1 (de) | Monoklonale menschliche antikörper gegen hiv-i | |
Etemad-Moghadam et al. | Characterization of simian-human immunodeficiency virus envelope glycoprotein epitopes recognized by neutralizing antibodies from infected monkeys | |
EP0242216A1 (de) | Nicht cytopathischer Klon von menschlichem T-Zellen lymphotropen Virus Typ-III | |
DK0480949T3 (da) | Fremstilling af virus og oprensning af virale kappeproteiner til vaccineanvendelse | |
Hejdeman et al. | DNA immunization with HIV early genes in HIV type 1-infected patients on highly active antiretroviral therapy | |
KR900702045A (ko) | 천연 hiv gp 160의 제조방법 | |
Bibollet-Ruche et al. | Complete genome analysis of one of the earliest SIVcpz Ptt strains from Gabon (SIVcpzGAB2) | |
EP0315459A2 (de) | Umvollständige HIV-Partikel und Verfahren zu ihrer Herstellung | |
CA2408786A1 (en) | Retroviral vectors comprising an enhanced 3' transcription termination structure | |
DK0592636T3 (da) | Fremgangsmåde til fremstilling af en levedygtig cellekultur, der er inficeret med en med dissemineret sklerose forbundet vi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |